Dihydro ergotamine mesylate
CAS: 6190-39-2
Ref. 3D-FD21918
1g | 586,00 € | ||
2g | 934,00 € | ||
100mg | 193,00 € | ||
250mg | 311,00 € | ||
500mg | 437,00 € |
Produktinformation
- (5'a,10a)-9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione
- (2'Ξ,5'Α,12'Ξ)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxo-9,10-Dihydroergotaman Methanesulfonate (Salt)
- (5'Alpha)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxo-9,10-Dihydroergotaman Methanesulfonate (Salt)
- (5'Alpha,10Alpha)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxo-9,10-Dihydroergotaman Methanesulfonate (1:1)
- 9,10-Dihydroergotamine mesylate
- Agit
- Angionorm
- Dergotamine
- Detms
- Dhe 45
- Mehr Synonyme anzeigen
- Diergo
- Dihydergot
- Dihydroergotamine Mesilate
- Dihydroergotamine Methanesulfonate
- Dihydroergotamine methanesulphonate
- Dihydroergotamine monomethanesulfonate
- Dihydroergotaminmesilat
- Dihytamine
- Dirgotarl
- Endophleban
- Ergomimet
- Ergont
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'α,10α)-, methanesulfonate (1:1)
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'α,10α)-, monomethanesulfonate (salt)
- Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, methanesulfonate (1:1)
- Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, monomethanesulfonate (salt)
- Ergotamine, 9,10-dihydro-, monomethanesulfonate (salt)
- Ergotonin
- Ikaran
- Mesilate De Dihydroergotamine
- Mesilato De Dihidroergotamina
- Migranal
- Morena
- Orstanorm
- Seglor
- Tonopres
- Verladyn
Dihydroergotamine mesylate is a medication that is used in the treatment of migraines. It belongs to the group of drugs called ergot alkaloids and has been shown to have high values in cerebral metabolism. Dihydroergotamine mesylate has also been shown to have an effect on dopamine levels in human serum, which may be due to its ability to inhibit neuronal death. Dihydroergotamine mesylate is administered intravenously, orally or intramuscularly for the treatment of acute migraine attacks. The drug can also be given rectally for the prevention of chronic migraine episodes. This drug may cause side effects such as nausea, vomiting and dizziness.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FD21918 Dihydro ergotamine mesylate
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.